All News #Library
Biotech
Qlaris Doses First Patient in Ph2 Nightingale Trial for Glaucoma
26 Aug 2025 //
PHARMAWEB
Qlaris Bio to Present Data on QLS-111 at 2025 Glaucoma Congress
23 Jun 2025 //
BUSINESSWIRE
Qlaris Develops Combo Therapy of QLS-111 With Latanoprost
11 Jun 2025 //
BUSINESSWIRE

Market Place
Sourcing Support